Abramova FA, et al. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
Proceedings of the National Academy of Sciences. 1993;90:2291–2294. [
PMC free article: PMC46072] [
PubMed: 8460135]
ACOG. Management of asymptomatic pregnant or lactating women exposed to anthrax.
Obstetrics and Gynecology. 2002;99:366–368. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice, Opinion No. 268. [
PubMed: 11814522]
Akhmerov DS, Kusov VN, Chernova AA.
Development of effective methods for preventing and treating infectious diseases of animals. 1982. Survival of
Bacillus anthracis in the tick
Dermacentor marginatus; pp. 101–103. Report of the Veterinary Institute, Karan. (Cited by
Hugh-Jones & de Vos, 2002)
Aleksandrov NL, et al. [Experience in massive aerogenic vaccination of people against anthrax].
Voyenno-Meditsinskii Zhurnal. 1959;8:27–32. (In Russian) [
PubMed: 13792503]
Alper T. Development of the “Sterne strain” of anthrax. Salisbury Medical Bulletin. 1996;87S:100–101.
Anderson GL, Simchock JM, Wilson KH. Identification of a region of genetic variability among
Bacillus anthracis strains and related species.
Journal of Bacteriology. 1996;178:377–384. [
PMC free article: PMC177668] [
PubMed: 8550456]
Andersson AP, Granum PE, Rönner U. The adhesion of
Bacillus cereus spores to epithelial cells might be an additional virulence mechanism.
International Journal of Food Microbiology. 1998;39:93–99. [
PubMed: 9562881]
Anon.. Report of the Departmental Committee appointed to inquire as to precautions for preventing danger of infection from anthrax in the manipulation of wool, goat hair and camel hair. Vol. 3. London: HMSO; 1918. Summary of evidence and appendices; p. 116.
Anon.. Handbook on contagious and infectious diseases in animals. Delhi: Government of India Press; 1945.
Anon.. Report of the Committee of Inquiry on Anthrax 1959. London: HMSO; 1959. (cmnd 846: 43–47, 90)
Anon.. Materiali 6-oi mezhinstitutskoi conferentsiyi pamyati I I; Mechnikova, Moscow. 11–13 May 1967; Moscow: Meditsina; 1967. (In Russian)
Anon.. Excretion of Bacillus anthracis through the milk after vaccination of cows against anthrax. Zoonosis – Quarterly Information Bulletin. 1970;12:42. (Cited in OAU/STRC Information Leaflet 18, No. 34, 1970)
Anon.. Bacterial infections from animals: anthrax. London: Public Health Laboratory Service, Communicable Diseases Surveillance Centre; 1982. Communicable disease report 82/12–15, 2 April 1982.
Anon.. Anthrax control and research, with special reference to national programme development in Africa: Memorandum from a WHO meeting.
Bulletin of the World Health Organization. 1994;72:13–22. [
PMC free article: PMC2486509] [
PubMed: 8131249]
Anon.. Bits and pieces (from the poster boards at the workshop). Salisbury Medical Bulletin. 1996;87S:139.
Anon.. Notice to readers: updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to
Bacillus anthracis.
Morbidity and Mortality Weekly Report. 2001;50:960. [
PubMed: 11708594]
Anon.. Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
Morbidity and Mortality Weekly Report. 2001;50:909–919. [
PubMed: 11699843]
Anon.. Notice to readers: update: interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.
Morbidity and Mortality Weekly Report. 2001;50:1014–1016. [
PubMed: 11724160]
Anon.. The microbiology of drinking-water. Bristol: Environment Agency; 2002. Methods for the examination of waters and associated materials.
Ascoli A. [Precipitin diagnosis of anthrax]. Zentrallblatt für Bakteriologie, Parasitenkunde und Infektionskrankheiten. 1911;58:63. (In German)
Ashford DA, Perkins BA, Rotz L. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices.
Morbidity and Mortality Weekly Report. 2000;49(RR-15):1–22. [
PubMed: 11145529]
Athamna A, et al. In vitro susceptibility of
Bacillus anthracis to various antibacterial agents and their time-kill activity.
Journal of Antimicrobial Chemotherapy. 2004;53:247–251. [
PubMed: 14688054]
Baillie LW, et al. Evaluation of the Biolog system for the identification of
Bacillus anthracis.
Letters in Applied Microbiology. 1995;20:209–211. [
PubMed: 7766114]
Baillie L, et al. Characterisation of the immune response to the UK human anthrax vaccine.
FEMS Immunology and Medical Microbiology. 2003;36:83–86. [
PubMed: 12727370]
Baillie LW, et al. Characterization of the human immune response to anthrax vaccine; Abstracts of the 2004 ASM Biodefense Research Meeting; Baltimore M.D., USA. 7–10 March 2004; 2004. abstract 77.
Baillie LW, Moore P, Manchee RJ. Development of a Bacillus subtilis based system for the expression of the protective antigen of Bacillus anthracis. Salisbury Medical Bulletin. 1996;87S:133–135.
Barnes JM. The development of anthrax following the administration of spores by inhalation. British Journal of Experimental Pathology. 1947;28:385–394.
Barnes JM. Penicillin and
B. anthracis.
Journal of Pathological Bacteriology. 1947;59:113–125. [
PubMed: 20266354]
Batty S, et al. Destabilization of IL-8 mRNA by Bacillus anthracis lethal toxin; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract 37.
Beall FA, Dalldorf FG. The pathogenesis of the lethal effect of anthrax toxin in the rat.
Journal of Infectious Diseases. 1966;116:377–389. [
PubMed: 4957317]
Beatty ME, et al. Gastrointestinal anthrax. Review of the literature.
Archives of Internal Medicine. 2003;163:2527–2531. [
PubMed: 14609791]
Bell WJ, Laing PW. Pulmonary anthrax in cattle.
Veterinary Record. 1977;100:573–574. [
PubMed: 888314]
Beyer W, Bartling C, Neubauer H. [Status of methods for detecting Bacillus anthracis in clinical and environmental samples]. Tierärztliche Umschau. 2003;58:653–662. (In German)
Beyer W, Pocivalsek S, Böhm R. Polymerase chain reaction-ELISA to detect
Bacillus anthracis from soil samples – limitations of present published primers.
Journal of Applied Microbiology. 1999;87:229–236. [
PubMed: 10475955]
Beyer W, et al. A nested PCR method for the detection of
Bacillus anthracis in environmental samples collected from former tannery sites.
Microbiology Research. 1995;150:179–186. [
PubMed: 7600011]
Beyer W, et al. A nested PCR and DNA-amplifcation-fingerprinting method for detection and identification of Bacillus anthracis in soil samples from former tanneries. Salisbury Medical Bulletin. 1996;87S:47–49.
Bhat P, Mohan DN, Srinivasa H. Intestinal anthrax with bacteriological investigations.
Journal of Infectious Diseases. 1985;152:1357–1358. [
PubMed: 4067334]
Blenkharn JI, Oakland D. Emission of viable bacteria in the exhaust flue gases from a hospital incinerator.
Journal of Hospital Infection. 1989;14:73–78. [
PubMed: 2570106]
Bloom WL, et al. Studies on infection with
Bacillus anthracis. IV. Preparation and characterization of an anthracidal substance from various animal tissue.
Journal of Infectious Diseases. 1947;80:41–52. [
PubMed: 20283796]
Böhm R. Resistance, survival, sterilization and disinfection of spores of Bacillus anthracis. Salisbury Medical Bulletin. 1990;68S:99–101.
Bourgogne A, et al. Global effects of virulence gene regulators in a
Bacillus anthracis strain with both virulence plasmids.
Infection and Immunity. 2003;71:2736–2743. [
PMC free article: PMC153248] [
PubMed: 12704148]
Bowen J. Factors affecting conventional and molecular detection of Bacillus anthracis in the environment and the stability of B.anthracis identification plasmids pX01 and pX02 in vitro. Milton Keynes: Open University; 1999. [PhD thesis]
Bowen JE, Turnbull PC. The fate of Bacillus anthracis in unpasteurized and pasteurized milk. Letters in Applied Microbiology. 1992;15:224–227.
Bowen JE, et al. Inactivation of Bacillus anthracis vegetative cells and spores by gamma irradiation. Salisbury Medical Bulletin. 1996;87S:70–72.
Braack LE, de Vos V. Feeding habits and flight range of blow-flies (
Chrysomyia spp.) in relation to anthrax transmission in the Kruger National Park, South Africa.
Onderstepoort Journal of Veterinary Research. 1990;57:141–142. [
PubMed: 2216348]
Brachman PS. Comments; Proceedings of the Symposium on Anthrax in Man; Philadelphia, P.A.. 8 October 1954; University of Pennsylvania; 1954. p. 34.
Brachman PS, Kaufmann AF. Anthrax. In: Evans AS, Brachman PS, editors. Bacterial infections of humans: epidemiology and control. 3rd ed. New York: Plenum Medical Book Co; 1998. pp. 95–107.
Brachman PS, et al. An epidemic of inhalation anthrax: the first in the twentieth century. 2. Epidemiology.
American Journal of Hygiene. 1960;72:6–23. [
PubMed: 13803672]
Bradley KA, et al. Identification of the cellular receptor for anthrax toxin.
Nature. 2001;414:225–229. [
PubMed: 11700562]
Bragg TS, Robertson L. Nucleotide sequence and analysis of the lethal factor gene (lef) from
Bacillus anthracis.
Gene. 1989;81:45–54. [
PubMed: 2509294]
Brini C, et al. Disinfection and decontamination of animal fibers: connected problems and state of the art. Salisbury Medical Bulletin. 1996;87S:78–79.
British Standards Institute. Code of practice for the identification of potentially contaminated land and its investigation. London: British Standards Institute; 1988.
Brookmeyer R, et al. The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak.
Biostatistics. 2001;2:233–247. [
PubMed: 12933552]
Brown ER, Cherry WB. Specific identification of
Bacillus anthracis by means of a variant bacteriophage.
Journal of Infectious Diseases. 1955;96:34–39. [
PubMed: 14354236]
Brunsdon JR. Unusual features in anthrax outbreaks. Veterinary Record. 1968;82:747–748.
Budd W. Observations on the occurrence of malignant pustule in England illustrated by numerous fatal cases. Association Medical Journal. 1863;1:85, 110, 159, 237.
Burans J, et al. Rapid method for the diagnosis of Bacillus anthracis infection in clinical samples using a hand-held assay. Salisbury Medical Bulletin. 1996;87S:36–37.
Buriro SN. Experimental inoculation of bacterial isolates obtained from Argas (persicargas) persicus in poultry. Journal of Applied Entomology. 1980;89:324–330.
Candela T, Mock M, Fouet A.
Bacillus anthracis Cap D, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O22. [
PubMed: 16045616]
Carl M, et al. Detection of spores of
Bacillus anthracis using the polymerase chain reaction.
Journal of Infectious Diseases. 1992;165:1145–1148. [
PubMed: 1583336]
Carter G, Balmer B. Chemical and biological warfare and defence, 1945–90. In: Bud R, Gummet P, editors. Cold war, hot science. Applied research in Britain’s defence laboratories, 1945–1990. Amsterdam: Harwood Academic Publishers; 1999. pp. 295–338.
Carter GB, Pearson GS. British biological warfare and biological defence, 1925–45. In: Geissler E, van Courtland Moon JE, editors. Biological and toxin weapons: research, developments and use from the Middle Ages to 1945. Oxford: Oxford University Press; 1999. pp. 168–189. SIPRI No. 18.
Cartwright ME, McChesney AE, Jones RL. Vaccination-related anthrax in three llamas.
Journal of the American Veterinary Medical Association. 1987;191:715–716. [
PubMed: 3119528]
Carucci JA, et al. Cutaneous anthrax management algorithm.
Journal of the American Academy of Dermatology. 2002;47:766–769. [
PubMed: 12399771]
Cavallo J-D, et al. Antibiotic susceptibilities of 96 isolates of
Bacillus anthracis isolated in France between 1994 and 2000.
Antimicrobial Agents and Chemotherapy. 2002;46:2307–2309. [
PMC free article: PMC127281] [
PubMed: 12069996]
CDSC. Anthrax surveillance 1961–80. PHLS Communicable Disease Report. 1981. p. 81/46.
CDSC. Bacterial infections from animals. PHLS Communicable Disease Report. 1982. p. 82/12.
Cendrowski S, MacArthur W, Hanna P.
Bacillus anthracis requires siderophore biosynthesis for growth in macrophages and mouse virulence.
Molecular Microbiology. 2004;51:407–417. [
PubMed: 14756782]
Centers for Disease Control and Prevention. Human ingestion of
Bacillus anthracis-contaminated meat – Minnesota, August 2000.
Journal of the American Medical Association. 2000;284:1644–1646. [
PubMed: 11041741]
Chabot DJ, et al. Anthrax capsule vaccine protects against experimental infection.
Vaccine. 2004;23:43–47. [
PubMed: 15519706]
Chabot DJ, et al. Capsule increases the efficacy of live attenuated Bacillus anthracis vaccines; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O41.
Chai Y, et al. Proteomics of early Bacillus anthracis-macrophage interactions; Abstracts of the ASM Biodefense Research Meeting; Baltimore, M.D., USA. 7–10 March 2004; 2004. abstract 159.
Chen Y, Tenover FC, Koehler TM. β-lactamase gene expression in a penicillin-resistant
Bacillus anthracis strain.
Antimicrobial Agents and Chemotherapy. 2004;48:4873–4877. [
PMC free article: PMC529205] [
PubMed: 15561870]
Christie AB. Anthrax. In: Christie AB, editor. Infectious diseases: epidemiology and clinical practice. Edinburgh: E and S Livingstone Ltd; 1969. pp. 752–759.
Clegg SB, et al. A massive outbreak of anthrax in the Malilangwe Wildlife Reserve, Zimbabwe. First record of anthrax in Zimbabwe wildlife?
Veterinary Record. 2006;160:113–118. [
PubMed: 17259452]
Cogne R, et al. Identification of Bacillus anthracis using the API 50CHB system. Salisbury Medical Bulletin. 1996;87S:34–35.
Cohen S, et al. Attenuated nontoxigenic and non-encapsulated recombinant
Bacillus anthracis spore vaccines protect against anthrax.
Infection and Immunity. 2000;68:4549–4558. [
PMC free article: PMC98371] [
PubMed: 10899854]
Coker PR, et al.
Bacillus anthracis virulence in guinea-pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality.
Journal of Clinical Microbiology. 2003;41:1212–1218. [
PMC free article: PMC150325] [
PubMed: 12624053]
Collins CH. Laboratory acquired infections. 2nd ed. London: Butterworths; 1988. p. 16.
Cote CK, Welkos SL. Studies on the roles of macrophages and neutrophils during infection with Bacillus anthracis; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O49.
Cote CK, Van Rooijen N, Welkos SL. Roles of macrophages and neutrophils in the early host responses to
Bacillus anthracis spores in a mouse model of infection.
Infection and Immunity. 2006;74:469–480. [
PMC free article: PMC1346637] [
PubMed: 16369003]
Cote CK, et al. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with
Bacillus anthracis spores.
Microbial Pathogenesis. 2004;37:169–175. [
PubMed: 15458777]
Cote CK, et al. The detection of spore-associated PA and the effects of anti-PA antibodies on
Bacillus anthracis spore germination and macrophage interactions.
Microbial Pathogenesis. 2005;38:209–225. [
PubMed: 15925272]
Coulson NM, Fulop M, Titball RW.
Bacillus anthracis protective antigen, expressed in
Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge.
Vaccine. 1994;12:1395–1401. [
PubMed: 7887017]
Cowan ST. Cowan and Steel’s manual for the identification of medical bacteria. Cambridge: Cambridge University Press; 1974.
Cromartie WJ, Bloom WL, Watson DW. Studies on infection with
Bacillus anthracis. 1. A histopathological study of skin lesions produced by
B. anthracis in susceptible and resistant animal species.
Journal of Infectious Diseases. 1947;80:1–13. [
PubMed: 20341537]
Cromartie WJ, et al. Studies of infection with
Bacillus anthracis. 2. The immunological and tissue damaging properties of extracts prepared from lesions of
B. anthracis infection.
Journal of Infectious Diseases. 1947;80:14–27. [
PubMed: 20283795]
Cui X, et al. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
Journal of Infectious Diseases. 2005;191:422–434. [
PubMed: 15633102]
Dahlgren CM, et al.
Bacillus anthracis aerosols in goat hair processing mills.
American Journal of Hygiene. 1960;72:6–23. [
PubMed: 13813720]
Dalldorf FG. Capillary thrombosis as a cause of death in experimental anthrax.
Archives of Pathology. 1967;83:154–161. [
PubMed: 6019568]
Dalldorf FG, Kaufmann AF, Brachman PS. Woolsorters’ disease. An experimental model.
Archives of Pathology. 1971;92:418–446. [
PubMed: 5001047]
Darlow HM, Pride NB. Serological diagnosis of anthrax.
Lancet. 1969;2:430. [
PubMed: 4184504]
Darlow HM, Belton FC, Henderson DW. The use of anthrax antigen to immunize man and monkey.
Lancet. 1956;271:476–479. [
PubMed: 13368432]
Davies JC. A major epidemic of anthrax in Zimbabwe. 1. The spread of the epidemic in Matabeleland, and Mashonaland Provinces during the period November 1978 to October 1980.
Central African Journal of Medicine. 1982;28:291–298. [
PubMed: 7168859]
Davies JC. A major epidemic of anthrax in Zimbabwe. 2. Distribution of cutaneous lesions.
Central African Journal of Medicine. 1983;29:8–12. [
PubMed: 6861201]
Davies JC. A major epidemic of anthrax in Zimbabwe. The experience at the Beatrice Road Infectious Disease Hospital, Harare.
Central African Journal of Medicine. 1985;31:176–180. [
PubMed: 4084971]
De Lalla F, et al. Familial outbreak of agricultural anthrax in an area of northern Italy.
European Journal of Clinical Microbiology and Infectious Diseases. 1992;11:839–842. [
PubMed: 1468425]
Demicheli V, et al. The effectiveness and safety of vaccines against human anthrax: a systematic review.
Vaccine. 1998;16:880–884. [
PubMed: 9682332]
De Moulin F, Soemenegara RM. [On the development of infection by the anthrax organism in the animal host]. Overgedrukt uit de Nederland-Indische Bladen voor Diergeneeskunde Deel. 1937;49:276–293. (In Dutch, summary in English)
De Vos V. The ecology of anthrax in the Kruger National Park, South Africa. Salisbury Medical Bulletin. 1990;68S:19–23.
De Vos V, Bryden HB. Anthrax in the Kruger National Park: temporal and spatial patterns of disease occurrence. Salisbury Medical Bulletin. 1996;87S:26–30.
De Vos V, Bryden HB. Anthrax in the Kruger National Park: the role of roan (Hippotragus equinus) and sable (H.niger) in the epidemiology of anthrax; Proceedings of the ARC–Onderstepoort international congress on anthrax, brucellosis, CBPP, clostridial and mycobacterial diseases; Berg-en Dal, Kruger National Park, South Africa. 9-15 August 1998; 1998. pp. 33–36.
De Vos V, Scheepers GJ. Remote mass vacination of large free-ranging wild animals for anthrax using Sterne spore vaccine. Salisbury Medical Bulletin. 1996;87S:116–121.
De Vos V, Turnbull PC. Anthrax. In: Coetzer JA, Thomson GR, Tustin RC, editors. Infectious diseases of livestock, with special reference to Southern Africa. 2nd ed. Vol. 3. Cape Town: Oxford University Press Southern Africa; 2004. pp. 1788–1818.
Deziel MR, et al. Effective antimicrobial regimens for use in humans for therapy of
Bacillus anthracis infections and postexposure prophylaxis.
Antimicrobial Agents and Chemotherapy. 2005;49:5099–5016. [
PMC free article: PMC1315931] [
PubMed: 16304178]
Dickerson BW, Campbell CJ, Stankard M. Further operating experience on biological purification of formaldehyde wastes; Proceedings of the Ninth Industrial Waste Conference; 1954. pp. 331–351.
Dietvorst DC. Farmers’ attitudes towards the control and prevention of anthrax in Western Province, Zambia. Salisbury Medical Bulletin. 1996;87S:102–103.
Dietvorst DC. Educational material on anthrax for villages in western Zambia. Salisbury Medical Bulletin. 1996;87S:104–106.
Dietz P, Böhm R. [Results of experimental testing of disinfectants with anthrax spores]. Hygiene und Medizin. 1980;5:103–107. (In German)
Dixon TC, et al. Anthrax.
New England Journal of Medicine. 1999;341:815–826. [
PubMed: 10477781]
Dixon TC, et al. Early
Bacillus anthracis-macrophage interactions: intracellular survival and escape.
Cellular Microbiology. 2000;2:453–463. [
PubMed: 11207600]
Doganay M. Human anthrax in Sivas, Turkey. Salisbury Medical Bulletin. 1990;68S:13.
Doganay M, Aydin N. Antimicrobial susceptibility of
Bacillus anthracis.
Scandinavian Journal of Infectious Diseases. 1991;23:333–335. [
PubMed: 1909051]
Doganay M, Almaç A, Hanagasi R. Primary throat anthrax.
Scandinavian Journal of Infectious Diseases. 1986;18:415–419. [
PubMed: 3775269]
Doganay M, Bakir M, Dokmetas I. A case of cutaneous anthrax with toxaemic shock.
British Journal of Dermatology. 1987;117:659–662. [
PubMed: 3689685]
Doi RH. Sporulation and germination. In: Harwood CR, editor. Bacillus. New York: Plenum Press; 1989. pp. 169–205.
Dong SL. Progress in the control and research of anthrax in China. Salisbury Medical Bulletin. 1990;68S:104–105.
Dragon DC, Elkin BT. An overview of early anthrax outbreaks in northern Canada: field reports of the Health of Animals Branch, Agriculture Canada, 1962-1971. Arctic. 2001;54:32–40.
Dragon DC, Rennie RP. Evaluation of spore extraction and purification methods for selective recovery of viable
Bacillus anthracis spores.
Letters in Applied Microbiology. 2001;33:100–105. [
PubMed: 11472515]
Dragon DC, Rennie RP, Gates CC. Bison and anthrax in northern Canada. Salisbury Medical Bulletin. 1996;87S:22–23.
Dragon DC, et al. A review of anthrax in Canada and implications for research on the disease in northern bison.
Journal of Applied Microbiology. 1999;87:208–213. [
PubMed: 10475950]
Druett HA, et al. Studies on respiratory infection with anthrax spores. 1. The influence of particle size on respiratory infection with anthrax spores.
Journal of Hygiene. 1953;51:359–371. [
PMC free article: PMC2217739] [
PubMed: 13096744]
Drum CL, et al. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin.
Nature. 2002;415:396–402. [
PubMed: 11807546]
Duesbury NS, et al. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.
Science. 1998;280:734–737. [
PubMed: 9563949]
Ebedes H. Anthrax epizootics in Etosha National Park. Madoqua. 1976;10:99–118.
Edginton AB. An outbreak of anthrax in pigs: a practitioner’s account.
Veterinary Record. 1990;127:321–324. [
PubMed: 2256239]
Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
Morbidity and Mortality Weekly Report. 2001;50:909–919. Editorial note. [
PubMed: 11699843]
Update: investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
Morbidity and Mortality Weekly Report. 2001;50:941–948. Editorial note. [
PubMed: 11708591]
Salisbury Medical Bulletin. 1996;87S:21. Editor’s note.
Salisbury Medical Bulletin. 1996;87S:104. Editor’s note.
Ellerbrok H, et al. Rapid and sensitive identification of pathogenic and apathogenic
Bacillus anthracis by real-time PCR.
FEMS Microbiology Letters. 2002;214:51–59. [
PubMed: 12204372]
Ellingson HV, et al. Cutaneous anthrax: report of twenty-five cases.
Journal of the American Medical Association. 1946;131:1105–1108. [
PubMed: 20992839]
Esel D, Doganay M, Sumerkan B. Antimicrobial susceptibilities of 40 isolates of
Bacillus anthracis isolated in Turkey.
International Journal of Antimicrobial Agents. 2003;22:70–72. [
PubMed: 12842331]
Eurich FW, Hewlett RT. Bacillus anthracis. In: Filde P, Ledingham JC, editors. A system of bacteriology in relation to medicine. Vol. 5. London: HMSO; 1930. pp. 439–478. Privy Council. Medical Research Council.
Ezzell JW, Abshire TG. Serum protease cleavage of
Bacillus anthracis protective antigen.
Journal of General Microbiology. 1992;138:543–549. [
PubMed: 1593265]
Ezzell JW, Abshire TG. Encapsulation of Bacillus anthracis spores and spore identification. Salisbury Medical Bulletin. 1996;87S:42.
Ezzell JW, Ivins BE, Leppla SH. Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of
Bacillus anthracis toxin.
Infection and Immunity. 1984;45:761–767. [
PMC free article: PMC263363] [
PubMed: 6432700]
Ezzell J, et al. In vivo formation of anthrax toxin in laboratory animals; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract P65.
FAO. Manual for the production of anthrax and blackleg vaccines. Rome: FAO; 1991. FAO Animal Production and Health Paper No. 87.
FAO/OIE/WHO. Animal health yearbook. Rome: FAO; 1992. FAO Animal Production and Health Paper No.32.
Fellows PF. A survey of worldwide strains of Bacillus anthracis. Salisbury Medical Bulletin. 1996;87S:31–33.
Ferguson LC. Anthrax. In: Leman AD, et al., editors. Diseases of swine. 5th ed. Ames: Iowa State University Press; 1981. pp. 396–400.
Fernelius AL. Comparison of two heat-shock methods and a phenol treatment method for determining germination rates of spores of
Bacillus anthracis.
Journal of Bacteriology. 1960;79:755–756. [
PMC free article: PMC278771] [
PubMed: 13822343]
Fildes P. Defensive aspects of biological warfare. London: Ministry of Supply; 1943. BDP Report No. 19.
Firoved AM, et al. Bacillus anthracis edemas toxin pathology in mice; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O50.
Forshaw D, et al. Anthrax in cattle in southern Western Australia.
Australian Veterinary Journal. 1996;74:391–393. [
PubMed: 8941423]
Fouet A, Mesnage S.
Bacillus anthracis cell envelope components. Koehler TM, editor.
Anthrax. Current Topics in Microbiology and Immunology. 2002;271:87–113. [
PubMed: 12224525]
Fouet A, Sirard J-C, Mock M. Virulence gene determinants. Salisbury Medical Bulletin. 1996;87S:84–85.
Fouet A, et al.
Bacillus anthracis surface: capsule and S-layer.
Journal of Applied Microbiology. 1999;87:251–255. [
PubMed: 10475960]
Fox MD, et al. Anthrax in Louisiana, 1971: epizootiologic study.
Journal of the American Veterinary Medical Association. 1973;163:446–451. [
PubMed: 4200691]
Fox MD, et al. An epizootiologic study of anthrax in Falls County, Texas.
Journal of the American Veterinary Medical Association. 1977;170:327–333. [
PubMed: 401803]
Franz DR, Parrott CD, Takafuji ET. The US biological warfare and biological defense programs. In: Sidell FR, Takafuj ET, Franz DR, editors. Medical aspects of chemical and biological warfare. Washington, D.C.: Borden Institute, Walter Reed Army Medical Center; 1997. pp. 425–436.
Frean J, et al. Susceptibility of
Bacillus anthracis to eleven antimicrobial agents including novel fluoroquinolones and a ketolide.
Journal of Antimicrobials and Chemotherapy. 2003;52:297–299. [
PubMed: 12865385]
Friedlander AM. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.
Journal of Biological Chemistry. 1986;261:7123–7126. [
PubMed: 3711080]
Friedlander AM, Welkos SL, Ivins BE. Anthrax vaccines. Koehler TM, editor.
Anthrax Current topics in microbiology and immunology. 2002;271:33–60. [
PubMed: 12224523]
Friedlander AM, et al. Postexposure prophylaxis against experimental inhalation anthrax.
Journal of Infectious Diseases. 1993;167:1239–1242. [
PubMed: 8486963]
Fritz DL, et al. Pathology of experimental anthrax in the rhesus monkey.
Laboratory Investigation. 1995;73:691–702. [
PubMed: 7474943]
Gates CC, Elkin BT, Dragon DC. Investigation, control and epizootiology of anthrax in a geographically isolated, free-roaming bison population in northern Canada.
Canadian Journal of Veterinary Research. 1995;59:256–264. [
PMC free article: PMC1263779] [
PubMed: 8548686]
Geissler E. Biological warfare activities in Germany 1923–45. In: Geissle E, van Courtland Moon JE, editors. Biological and toxin weapons: research, development and use from the Middle Ages to 1945. Oxford: Oxford University Press; 1999. pp. 91–126. SIPRI Chemical and Biological Warfare Studies 18.
George S, et al. An outbreak of anthrax meningoencephalitis.
Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994;88:206–207. [
PubMed: 8036676]
German Society of Hygiene and Microbiology. [Guidelines for the testing of chemical disinfectants]. Stuttgart: Gustav Fischer Verlag; 1972. (In German)
German Veterinary Medical Society. Fourth edition. [Guidelines for testing disinfection procedures and chemical disinfectants]. Giessen: DVG Verlag; 2007. (In German)
Gibbons DF, Hussaini SN. Isolation of Bacillus anthracis from an aborted bovine fetus. Nature. 1974;252:612.
Gleiser CA. Pathology of anthrax infection in animal hosts.
Federation Proceedings. 1967;26:1518–1521. [
PubMed: 4963766]
Gleiser CA, Gochenour WS, Ward MK. Pulmonary lesions in dogs and pigs exposed to a cloud of anthrax spores.
Journal of Comparative Pathology. 1968;78:445–448. [
PubMed: 4971601]
Gochenour WS, et al. Efficacy of anthrax biologics in producing immunity in previously unexposed animals. Washington, D.C.: United States Department of Agriculture; 1935. Technical Bulletin 468.
Gold H. Anthrax. A report of one hundred seventeen cases.
Archives of Internal Medicine. 1955;96:387–396. [
PubMed: 13248274]
Gold H. Treatment of anthrax.
Federation Proceedings. 1967;26:1563–1568. [
PubMed: 6051335]
Gold JA, et al. Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by
Bacillus anthracis.
Infection and Immunity. 2004;72:1291–1297. [
PMC free article: PMC356021] [
PubMed: 14977930]
Gordon RE, Haynes WC, Pang CH. The genus Bacillus. Washington, D.C.: United States Government Printing Office; 1973. (Agriculture Handbook 427). Agriculture Research Service, United States Department of Agriculture.
Goring CA, Hamaker IW. Organic chemicals in the soil environment. New York: Dekker; 1972.
Granum PE, et al. Enterotoxin from Bacillus cereus: production and biochemical characterization. Netherlands Milk and Dairy Journal. 1993;47:63–70.
Greenberg B. Flies and Disease. Vol 1. Princeton: Princeton University Press; 1971.
Greenberg B. Flies and Disease. Vol 2. Princeton: Princeton University Press; 1973.
Greenfield WS. Lectures on some recent investigations into the pathology of infectious and contagious diseases. Lecture 3, part 1. Lancet. 1880;1:865–867. (Cited by Tigertt 1980, Journal of Hygiene, 85:415-420)
Grigoryan M.
Deadly diet: zoo animals found dead after eating infected meat. Nov 8, 2002.
ArmeniaNow.com.
Guidi-Rontani C, Mock M. Macrophage interactions. Koehler TM, editor.
Anthrax Current Topics in Microbiology and Immunology. 2002;271:115–141. [
PubMed: 12224520]
Guidi-Rontani C, Levy M, Mock M. Interaction of Bacillus anthracis spores with macrophages; Proceedings of the fourth international conference on anthrax; Annapolis, M.D., USA. 10–13 June 2001; 2001. p. 17.
Guidi-Rontani C, et al. Germination of
Bacillus anthracis spores within alveolar macrophages.
Molecular Microbiology. 1999;31:9–17. [
PubMed: 9987105]
Guidi-Rontani C, et al. Fate of germinated
Bacillus anthracis spores in primary murine macrophages.
Molecular Microbiology. 2001;42:931–938. [
PubMed: 11737637]
Gumbel P. Sverdlosk. What really happened? Wall Street Journal. Oct 21, 22, 23, 1991.
Haas CN. On the risk of mortality to primates exposed to anthrax spores.
Risk Analysis. 2002;22:189–193. [
PubMed: 12022669]
Hachisuka Y. Germination of
Bacillus anthracis spores in the peritoneal cavity of rats and establishment of anthrax.
Japanese Journal of Microbiology. 1969;13:199–207. [
PubMed: 4980413]
Hanna PC. Establishment stage of anthrax infections; Proceedings of the fourth international conference on anthrax; Annapolis, M.D., USA. 10–13 June 2001; 2001. p. 17.
Hanna P, Ireland J. Understanding
Bacillus anthracis pathogenesis.
Trends in Microbiology. 1999;7:180–182. [
PubMed: 10383221]
Harris S. The Japanese biological warfare programme: an overview. In: Geissle E, van Courtland Moon JE, editors. Biological and toxin weapons: research, development and use from the Middle Ages to 1945. Oxford: Oxford Univerity Press; 1999. pp. 127–152. SIPRI Chemical and Biological Warfare Studies 18.
Healing TD, Hoffman PN, Young SE. The infection hazards of human cadavers.
PHLS Communicable Disease Report. 1995;5:R61–R68. [
PubMed: 7749455]
Henderson I. Fingerprinting Bacillus anthracis strains. Salisbury Medical Bulletin. 1996;87S:55–58.
Heninger SJ, et al. Toxins are not required for lethality in a murine model for inhalation anthrax; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O47.
Henning O. Annual report to the College of Veterinary Surgeons. C.G.H.; 1893. (Cited by de Vos & Turnbull, 2004)
Henry M. A further note on the incidence of anthrax in stock in Australia. Australian Veterinary Journal. 1936;12:235–239.
Henton MM, Briers GF. Anthrax spores isolated above burning carcasses; Proceedings of the ARC-Onderstepoort international congress on anthrax, brucellosis, CBPP, clostridial and mycobacterial diseases; Kruger Park, South Africa. 9–15 August 1998; Onderstepoort: Onderstepoort Veterinary Institute; 1998. pp. 37–40.
Herbst RM. The transamination reaction. Advances in Enzymology. 1944;4:75–97.
Higgins CH. Anthrax. Ottawa: Department of Agriculture; 1916. Bulletin No. 23.
Hodgson AE. Cutaneous anthrax. Lancet. 1941;237:811–813.
Housewright RD, Thorne CB. Synthesis of glutamic acid and glutamyl polypeptide by
Bacillus anthracis I. Formation of glutamic acid by transamination.
Journal of Bacteriology. 1950;60:89–100. [
PMC free article: PMC385843] [
PubMed: 15436464]
Howie JW. Some factors governing the formation of spores in
Bacillus anthracis.
Society for General Microbiology: proceedings. 1949;3 [
PubMed: 18126525]
Hudson JR. Anthrax – some observations. State Veterinary Journal. 1953;8:28–30.
Hugh-Jones ME, de Vos V. Anthrax and wildlife.
Revue Scientifique et Technique de l’Office International des Epizooties. 2002;21:359–383. [
PubMed: 11974621]
Hugh-Jones ME, Hussaini SN. An anthrax outbreak in Berkshire.
Veterinary Record. 1974;94:228–232. [
PubMed: 4207208]
Hugh-Jones ME, Hussaini SN. Anthrax in England and Wales 1963-72.
Veterinary Record. 1975;97:256–261. [
PubMed: 1179615]
Hutson RA, et al. The development and assessment of DNA and oligonucleotide probes for the specific detection of
Bacillus anthracis.
Journal of Applied Bacteriology. 1993;75:463–472. [
PubMed: 8300447]
Hutyra F, Marek J, Manninger R. Infectious diseases. In: Grie R, Mohler JR, Eichhor A, editors. Special pathology and therapeutics of the diseases of domestic animals. 5th English ed. Vol. 1. Chicago: Alexander Eger; 1946. pp. 1–35.
Iacono-Connors LC, et al. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.
Infection and Immunity. 1991;59:1961–1965. [
PMC free article: PMC257950] [
PubMed: 1903769]
Inglesby TV, et al. Anthrax as a biological weapon. Medical and public health management.
Journal of the American Medical Association. 1999;281:1735–1745. [
PubMed: 10328075]
Inglesby TV, et al. Anthrax as a biological weapon, 2002. Updated recommendations for management.
Journal of the American Medical Association. 2002;287:2236–2252. [
PubMed: 11980524]
Ivanova N, et al. Genome sequence of
Bacillus cereus and comparative analysis with
Bacillus anthracis.
Nature. 2003;423:87–91. [
PubMed: 12721630]
Ivanovics G. [The fate of the capsular substance (P substance) of anthrax bacilli in the organism]. Zeitschrift fur Immunistätsforschung. 1939;96:408–412. (In German)
Ivanovics G, Bruckner V. [The chemistry of the capsule substance of B. anthracis and its identity with that of B. mesentericus]. Zeitschrift fur Immunistätsforschung. 1937;90:304–318. (In German)
Ivanovics G, Bruckner V. [A follow-up note: chemical and immunological studies on the mechanism of anthrax infection and immunity]. Zeitschrift fur Immunistätsforschung. 1937;91:175–176. (In German)
Ivins BE, Welkos SL. Recent advances in the development of an improved anthrax vaccine.
European Journal of Epidemiology. 1988;4:12–19. [
PubMed: 3128450]
Ivins BE, et al. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of
Bacillus anthracis and with recombinant strains of
Bacillus subtilis that produce anthrax protective antigen.
Infection and Immunity. 1990;58:303–308. [
PMC free article: PMC258455] [
PubMed: 2105269]
Ivins BE, et al. Cloned protective activity and progress in development of improved anthrax vaccines. Salisbury Medical Bulletin. 1990;68S:86–88.
Ivins BE, et al. Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Medical Bulletin. 1996;87S:125–126.
Ivins BE, et al. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques.
Vaccine. 1998;16:1141–1148. [
PubMed: 9682372]
Jackson FC, Wright GG, Armstrong J. Immunization of cattle against experimental anthrax with alum-precipitated protective antigen or spore vaccine.
American Journal of Veterinary Research. 1957;18:771–777. [
PubMed: 13470233]
Jackson PJ, et al. Characterization of the variable-number tandem repeats in vrrA from different
Bacillus anthracis isolates.
Applied and Environmental Microbiology. 1997;63:1400–1405. [
PMC free article: PMC168435] [
PubMed: 9097438]
Jackson PJ, et al. PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims. The presence of multiple
Bacillus anthracis strains in different victims.
Proceedings of the National Academy of Sciences. 1998;95:1224–1229. [
PMC free article: PMC18726] [
PubMed: 9448313]
Jackson R. The introduction into Great Britain of anthrax infection by means of products of animal origin. Journal of Comparative Pathology and Therapeutics. 1930;43:95–98.
Jacotot H, Virat B. [Long duration of viability of spores of
Bacillus anthracis].
Annales de l’Institut Pasteur. 1954;87:215–217. (In French) [
PubMed: 13197885]
Jefferds MD, et al. Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001.
Emerging Infectious Diseases. 2002;8:1138–1144. [
PMC free article: PMC2730315] [
PubMed: 12396929]
Jensen R. Diseases of sheep. Philadelphia: Lea & Febiger; 1974.
Johns M, et al. Improved methods for the detection of Bacillus anthracis spores by the polymerase chain reaction. Letters in Applied Microbiology. 1994;18:236–238.
Jones ME, et al. Antibiotic susceptibility of isolates of
Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Clinical Microbiology and Infection. 2003;9:984–986. [
PubMed: 14616693]
Jones MN, Turnbull PC. Disinfection against spores of Bacillus anthracis. Salisbury Medical Bulletin. 1996;87S:74–78.
Kadanali A, Tasyaran MA, Kadanali S. Anthrax during pregnancy: case reports and review.
Clinical Infectious Diseases. 2003;36:1343–1346. [
PubMed: 12746784]
Kanungo R, et al. Problem of timely diagnosis in anthrax meningitis.
Journal of the Association of Physicians of India. 2002;50:913–915. [
PubMed: 12126347]
Kaufmann AF. Observations on the occurrence of anthrax as related to soil type and rainfall. Salisbury Medical Bulletin. 1990;68S:16–17.
Keim P, Smith KL.
Bacillus anthracis evolution and epidemiology. Koehler TM, editor.
Anthrax. Current Topics in Microbiology and Immunology. 2002;271:23–32. [
PubMed: 12224522]
Keim P, et al. Molecular evolution and diversity in
Bacillus anthracis as detected by amplified fragment length polymorphism markers.
Journal of Bacteriology. 1997;179:818–824. [
PMC free article: PMC178765] [
PubMed: 9006038]
Keim P, et al. Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within
Bacillus anthracis.
Journal of Bacteriology. 2000;182:2928–2936. [
PMC free article: PMC102004] [
PubMed: 10781564]
Kelsey JC, Sykes G. A new test for the assessment of disinfectants with particular reference to their use in hospitals. Pharmacology Journal. 1969;202:607–609.
Keppie J, Smith A, Harris-Smith PW. The chemical basis of the virulence of
Bacillus anthracis 3: the role of the terminal bacteraemia in death of guinea-pigs from anthrax.
British Journal of Experimental Pathology. 1955;36:315–322. [
PMC free article: PMC2082520] [
PubMed: 13239988]
Keymer IF. Diseases of birds of prey.
Veterinary Record. 1972;90:579–594. [
PubMed: 5073130]
Khanne N, Gokul BN, Ravikumar R. Successfully treated primary anthrax meningitis.
Indian Journal of Pathology and Microbiology. 1989;32:315–317. [
PubMed: 2517270]
Kiel JL, et al. Rapid recovery and identification of anthrax bacteria from the environment.
Tropical Veterinary Diseases. 2000;916:240–252. [
PubMed: 11193628]
Klein F, et al. Anthrax toxin: causative agent in the death of rhesus monkeys.
Science. 1962;138:1331–1333. [
PubMed: 14033353]
Klemm DM, Klemm WR. A history of anthrax.
Journal of the American Veterinary Medical Association. 1959;135:458–462. [
PubMed: 14409786]
Klichko VI, et al. Anaerobic induction of
Bacillus anthracis hemolytic activity.
Biochemical and Biophysical Research Communications. 2003;303:855–862. [
PubMed: 12670489]
Knight BC, Proom H. A comparative survey of the nutrition and physiology of mesophilic species in the genus
Bacillus.
Journal of General Microbiology. 1950;4:508–538. [
PubMed: 14778957]
Kobuch WE, et al. A clinical and epidemiological study of 621 patients with anthrax in western Zimbabwe. Salisbury Medical Bulletin. 1990;68S:34–38.
Koehler TM.
Bacillus anthracis genetics and virulence gene regulation. Koehler TM, editor.
Anthrax. Current Topics in Microbiology and Immunology. 2002;271:143–164. [
PubMed: 12224521]
Koshi G, et al. Anthrax meningitis: a rare clinical entity.
Journal of the Association of Physicians of India. 1981;29:59–62. [
PubMed: 6790511]
Kozel TR, et al. mAbs to
Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
Proceedings of the National Academy of Sciences. 2004;101:5042–5047. [
PMC free article: PMC387370] [
PubMed: 15051894]
Kraneveld FC, Djaenoedin R. [Test on the dissemination of anthrax by Tabanus rubidus, in horses and buffalo]. Overgedrukt uit de Nederlands-Indische Bladen Voor Diergeneeskunde. 1940;52:339–380. (In Dutch, summary in English)
Kraneveld FC, Mansjoer M. [Anthrax bacilli in the digestive tract of Tabanus rubidus]. Overgedrukt uit de Nederlands-Indische Bladen Voor Diergeneeskunde. 1939;51:62–75. (In Dutch, summary in English)
Kraneveld FC, Mansjoer M. [The spread of anthrax by carrion eaters]. Overgedrukt uit de Nederlands-Indische Bladen Voor Diergeneeskunde. 1941;53:313–340. (In Dutch, summary in English)
Lacy DB, Collier RJ. Structure and function of anthrax toxin. Koehler TM, editor.
Anthrax. Current Topics in Microbiology and Immunology. 2002;271:61–85. [
PubMed: 12224524]
Lalitha MK, et al. Primary anthrax presenting as an injection “abscess”
Indian Journal of Pathology and Microbiology. 1988;31:254–256. [
PubMed: 3148549]
Lalitha MK, et al. Unusual forms of anthrax – a clinical problem. Salisbury Medical Bulletin. 1990;68S:38–40.
Lalitha MK, et al. Anthrax – a continuing problem in Southern India. Salisbury Medical Bulletin. 1996;87S:14–15.
Lanska D. Anthrax meningoencephalitis.
Neurology. 2002;59:327–334. [
PubMed: 12177364]
Lebedinski VA. Moscow: Meditsina; 1971. (In Russian; English translation published by Boston Spa, West Yorkshire)
Lee LA, Kidd AR, Sterne M. Antibiotic treatment and its effect on anthrax immunization. Veterinary Record. 1961;73:1426.
Leendertz FH, et al. Anthrax kills wild chimpanzees in a tropical rainforest.
Nature. 2004;430:451–452. [
PubMed: 15269768]
Leonard CG, Housewright RD. Polyglutamic acid synthesis by cell-free extracts of
Bacillus licheniformis.
Biochimica et Biophysica Acta. 1963;73:530–532. [
PubMed: 14068536]
Leppla SH. The anthrax toxin complex. In: Alouf JE, Freer JH, editors. Sourcebook of bacterial protein toxins. New York: Academic Press; 1991. pp. 277–302.
Leppla SH, Ivins BE, Ezzell JW. Anthrax toxin. In: Lorett L, editor. Microbiology – 1985. Washington, D.C.: American Society for Microbiology; 1985. pp. 63–66.
Levy LM, et al. Anthrax meningitis in Zimbabwe.
Central African Journal of Medicine. 1981;27:101–104. [
PubMed: 7261058]
Lewis-Jones MS, et al. Cowpox can mimic anthrax.
British Journal of Dermatology. 1993;129:625–627. [
PubMed: 8251366]
Liang X, Yu D. Identification of
Bacillus anthracis strains in China.
Journal of Applied Microbiology. 1999;87:200–203. [
PubMed: 10475948]
Lightfoot NF, Scott RJ, Turnbull PC. Antimicrobial susceptibility of Bacillus anthracis. Salisbury Medical Bulletin. 1990;68S:95–98.
Lim N-K, et al. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
Infection and Immunity. 2005;73:6547–6551. [
PMC free article: PMC1230968] [
PubMed: 16177329]
Lincoln RE, et al. Pathogenesis as related to physiological state of anthrax spore and cell. In: Halvorson HO, editor. Spores II. Minneapolis: Burgess Publishing; 1961. pp. 255–273.
Lincoln RE, et al. Successful treatment of rhesus monkeys for septicemic anthrax.
Antimicrobial Agents and Chemotherapy. 1964;4:759–763. [
PubMed: 14288031]
Lincoln RE, et al. Value of field data for extrapolation in anthrax.
Federation Proceedings. 1967;26:1558–1562. [
PubMed: 4963771]
Lindeque PM, Turnbull PC. Ecology and epidemiology of anthrax in the Etosha National Park, Namibia.
Onderstepoort Journal of Veterinary Research. 1994;61:71–83. [
PubMed: 7898901]
Lindeque PM, Brain C, Turnbull PC. A review of anthrax in the Etosha National Park. Salisbury Medical Bulletin. 1996;87S:24–26.
Lindeque PM, et al. Anthrax vaccine-induced seroconversion in zebra and elephant in the Etosha National Park, Namibia. Salisbury Medical Bulletin. 1996;87S:113–115.
Lindeque PM, et al. Anthrax in wild cheetahs in the Etosha National Park, Namibia; Proceedings of the ARC– Onderstepoort international congress on anthrax, brucellosis, CBPP, clostridial and mycobacterial diseases; Kruger National Park, South Africa. 9–15 August 1998; 1998. pp. 9–15.
Lindley EP. Anthrax – the carrier state. British Veterinary Journal. 1955;111:215–217.
Lindner F, Böhm R. Effect of lime on spores of B anthracis in the sludge of a treatment plant connected with some tanneries. In: Strauc D, Havelaar AH, Hermite PL, editors. Inactivation of microorganisms in sewage sludge by stabilisation processes. London: Elsevier Applied Science Publications; 1985. pp. 113–117.
Lindner F, Böhm R, Strauch D. [Chemical procedures for killing anthrax spores in sewage sludge]. Forum Stadte-Hygiene. 1987;38:306–312. (In German)
Logan NA, Berkeley RC. Classification and identification of members of the genus Bacillus using API tests. In: Berkeley RC, Goodfello M, editors. The aerobic endosporeforming bacteria: classification and identification. London: Academic Press; 1981. pp. 105–140.
Logan NA, Berkeley RC. Identification of
Bacillus strains using the API system.
Journal of General Microbiology. 1984;130:1871–1882. [
PubMed: 6432953]
Logan NA, et al. Identification of
Bacillus anthracis by API tests.
Journal of Medical Microbiology. 1985;20:75–85. [
PubMed: 3927004]
Lyon DG. An outbreak of anthrax at the Chester Zoological Gardens.
Veterinary Record. 1973;92:334–337. [
PubMed: 4198672]
MAFF. Anthrax. London: Department for Environment, Food and Rural Affairs; 1992. Instruction to the Ministry of Agriculture, Fisheries and Food veterinary staff (United Kingdom). (Chapter 2, appendix 2) (unpublished document)
Makino S, et al. Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in
Bacillus anthracis.
Journal of Bacteriology. 1989;171:722–730. [
PMC free article: PMC209657] [
PubMed: 2536679]
Manchee RJ, et al.
Bacillus anthracis on Gruinard Island.
Nature. 1981;294:254–255. [
PubMed: 6795509]
Manchee RJ, et al. Decontamination of
Bacillus anthracis on Gruinard Island?
Nature. 1983;303:239–240. [
PubMed: 6405284]
Manchee RJ, et al. 1990Out of Gruinard Island Salisbury Medical Bulletin 68S:17–18.
Manchee RJ, et al. Formaldehyde solution effectively inactivates spores of
Bacillus anthracis on the Scottish island of Gruinard.
Applied and Environmental Microbiology. 1994;60:4167–4171. [
PMC free article: PMC201953] [
PubMed: 16349444]
Mangold BL, Aldrich JA, Nelson WM. Generation of spore-specific and vegetative-specific murine monoclonal antibodies highly restricted to Bacillus anthracis; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O12.
Marano N, et al. Interim analysis of anthrax vaccine human reactogenicity and immunogenicity clinical trial; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O51.
Marburger RG, Thomas JW. A die-off in white-tailed deer of the central mineral region of Texas. Journal of Wildlife Management. 1965;29:706–716.
Marchette NJ, Lundgren DL, Smart KL. Intracutaneous anthrax infection in wild rodents.
Journal of Infectious Diseases. 1957;101:148–153. [
PubMed: 13475872]
Martin D. The use of poison and biological weapons in the Rhodesian war. Harare: Southern African Research and Documentation Centre; 1993. (Transcript of a lecture for the War and Strategic Studies Seminar Series). University of Zimbabwe, 7 July 1993.
Martin GH. Cutaneous anthrax in rural Ethiopia. A study of one hundred consecutive cases; their clinical features and epidemiology. Dundee: University of Dundee; 1975. [MD Thesis]
Maynard JA, et al. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
Nature Biotechnology. 2002;20:597–601. [
PubMed: 12042864]
McBride BW, et al. Protective efficacy of a recombinant protective antigen against
Bacillus anthracis challenge and assessment of immunological markers.
Vaccine. 1998;16:810–817. [
PubMed: 9627938]
McCann KP, et al. Alanine germination receptors of
Bacillus subtilis.
Letters in Applied Microbiology. 1996;23:290–294. [
PubMed: 8987707]
McCloy EW. Lysogenicity and immunity to
Bacillus phage W.
Journal of General Microbiology. 1958;18:198–220. [
PubMed: 13525640]
McCulloch B. Pulmonary anthrax in cattle. Veterinary Record. 1961;73:805.
McGaughey CA, Chu HP. The egg-yolk reaction of aerobic sporing bacilli. Journal of General Microbiology. 1948;2:334–340.
McKendrick DR. Anthrax and its transmission to humans.
Central African Journal of Medicine. 1980;26:126–129. [
PubMed: 7407891]
Meselson M, et al. The Sverdlovsk anthrax outbreak of 1979.
Science. 1994;266:1202–1208. [
PubMed: 7973702]
Mesnage S, et al. The S-layer homology domain as a means for anchoring heterologous proteins on the cell surface of
Bacillus anthracis.
Journal of Applied Microbiology. 1999;87:256–260. [
PubMed: 10475961]
Meynell EW. Reverting and non-reverting rough variants of
Bacillus anthracis.
Journal of General Microbiology. 1963;32:55–60. [
PubMed: 14045523]
Meynell E, Meynell GG. The roles of serum and carbon dioxide in capsule formation by
Bacillus anthracis.
Journal of General Microbiology. 1964;34:153–164. [
PubMed: 14121214]
Meynell GG, Lawn AM. Inheritance of capsule and the manner of cell-wall formation in
Bacillus anthracis.
Journal of General Microbiology. 1965;39:423–427. [
PubMed: 4955833]
Meynell GG, Meynell E. The biosynthesis of poly-D-glutamic acid, the capsular material of
Bacillus anthracis.
Journal of General Microbiology. 1966;43:119–138. [
PubMed: 4959278]
M’Fadyean J. A further note with regard to the staining reaction of anthrax blood with methylene blue. Journal of Comparative Pathology. 1903;16:360–361.
M’Fadyean J. Anthrax bacilli in milk. Journal of Comparative Pathology. 1909;22:148–149.
Mignot T, Mock M, Fouet A. A plasmid-encoded regulator couples the synthesis of toxins and surface structures in
Bacillus anthracis.
Molecular Microbiology. 2003;47:917–927. [
PubMed: 12581349]
Mignot T, et al. The incompatibility between the PlcR- and AtxA-controlled regulons may have selected a nonsense mutation in
Bacillus anthracis.
Molecular Microbiology. 2001;42:1189–1198. [
PubMed: 11886551]
Minett FC. Sporulation and viability of
B. anthracis in relation to environmental temperature and humidity.
Journal of Comparative Pathology and Therapeutics. 1950;60:161–176. [
PubMed: 14814223]
Minett FC. The use of climatological data for assessing the regional distribution of anthrax in India. Bulletin de l’ Office International des Epizooties. 1951;35:266–295.
Minett FC. The annual and seasonal incidence of anthrax in various countries. Climatic effects and sources of infection. Bulletin de l’Office International des Epizooties. 1952;37:238–301.
Minett FC, Dhanda MR. Multiplication of B. anthracis and Cl. chauvoei in soil and water. Indian Journal of Veterinary Science and Animal Husbandry. 1941;11:308–321.
Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis.
Current Opinion in Microbiology. 2004;7:19–24. [
PubMed: 15036135]
Moayeri M, et al.
Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.
Journal of Clinical Investigation. 2003;112:670–682. [
PMC free article: PMC182199] [
PubMed: 12952916]
Mohamed N, et al. A high-affinity monoclonal antibody to anthrax protective antigen passively protects rabbits before and after aerosolized
Bacillus anthracis spore challenge.
Infection and Immunity. 2005;73:795–802. [
PMC free article: PMC547027] [
PubMed: 15664918]
Mohammed MJ, et al. Antimicrobial susceptibility testing of
Bacillus anthracis: comparison of results obtained using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods.
Journal of Clinical Microbiology. 2002;40:1902–1907. [
PMC free article: PMC130796] [
PubMed: 12037041]
Morris H. Anthrax: transmission of infection by non-biting flies. Bulletin of the Louisiana State University, Agriculture Experiment Station. 1918;163:3–15.
Morris H. Blood-sucking insects as transmitters of anthrax or charbon. Bulletin of the Louisiana State University, Agriculture Experiment Station. 1919;168:3–12.
Morris H. Some carriers of anthrax infection. Journal of the American Veterinary Medical Association. 1920;56:606–608.
Mosser E, et al. Effects of the Bacillus anthracis toxin anthrolysin O – a toll like receptor 4 (TLR4) agonist – on human neutrophil and macrophage function; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O39.
Muller JD, et al. Specificity of an immunochromatographic test for anthrax.
Australian Veterinary Journal. 2004;82:220–222. [
PubMed: 15149073]
Musa MT, et al. Anthrax in humans and camels in the Sudan with reference to the disease in the country.
Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux. 1993;46:438–439. [
PubMed: 8190979]
Nalin DR, et al. Survival of a patient with intestinal anthrax.
American Journal of Medicine. 1977;62:130–132. [
PubMed: 835581]
Nass M. Anthrax epizootic in Zimbabwe 1978–1980: due to deliberate spread? Physicians for Social Responsibility Quarterly. 1992;2:198–209.
Navacharoen N, et al. Oropharyngeal anthrax.
Journal of Laryngology and Otology. 1985;99:1293–1295. [
PubMed: 3934300]
Ndyabahinduka DG, et al. An outbreak of human gastrointestinal anthrax.
Annali dell’Istituto Superiore di Sanità 1984;20:205–208. [
PubMed: 6545639]
Nicholson WL, Setlow P. Sporulation, germination and outgrowth. In: Harwood CR, Cutting SM, editors. Molecular biological methods for Bacillus. Chichester: John Wiley and Sons; 1990. pp. 391–450.
Nieberle K, Cohrs P. Textbook of the special pathological anatomy of domestic animals. New York: Pergamon Press; 1967.
Norman PS, et al. Serologic testing for anthrax antibodies in workers in a goat hair processing mill.
American Journal of Hygiene. 1960;72:32–37. [
PubMed: 14427621]
Odendaal MW, et al. The antibiotic sensitivity patterns of
Bacillus anthracis isolated from the Kruger National Park.
Onderstepoort Journal of Veterinary Research. 1991;58:17–19. [
PubMed: 1905000]
Ogarkov VE, Gapochko KG. Moscow: Meditsina; 1975. (In Russian)
Oh HB, Park KS, Park KD. Serological detection of human anthrax in Korean outbreaks 1992–1995. Salisbury Medical Bulletin. 1996;87S:19–20.
OIE. Terrestrial Animal Health Code. Paris: World Organisation for Animal Health (OIE); 2007.
OIE. Manual of diagnostic tests and vaccines for terrestrial animals. Paris: World Organisation for Animal Health (OIE); 2008.
Onerci M, Ergin NT. [Oropharyngeal anthrax].
Laryngo-Rhino-Otologie. 1993;72:350–351. (In German, summary in English) [
PubMed: 8369089]
Orr JP, Johnston WG, Morrison JR. Anthrax lesions in a zoo cat.
Veterinary Record. 1978;102:312–313. [
PubMed: 654038]
Pannifer AD, et al. Crystal structure of the anthrax lethal factor.
Nature. 2001;414:229–233. [
PubMed: 11700563]
Park YM, Seong WK, Oh HB. Monoclonal antibody against spore surface antigen of B. anthracis; Third International Conference on Anthrax; University of Plymouth, United Kingdom. 1998. Abstract P30.
Parry JM, Turnbull PC, Gibson JR. A colour atlas of Bacillus species. London: Wolfe Publishing Ltd.; 1983. (Wolfe Medical Atlases Series No. 19).
Patra G, et al. Specific oligonucleotide primers for rapid identification of Bacillus anthracis strains. Salisbury Medical Bulletin. 1996;87S:45–46.
Patra G, et al. Isolation of a specific chromosomic DNA sequence of
Bacillus anthracis and its possible use in diagnosis.
FEMS Immunology and Medical Microbiology. 1996;672:1–8. [
PubMed: 8908483]
Peterson JW, et al. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea-pigs against inhalation anthrax.
Infection and Immunity. 2006;74:1016–1024. [
PMC free article: PMC1360364] [
PubMed: 16428748]
Petosa C, et al. Crystal structure of the anthrax toxin protective antigen.
Nature. 1997;385:833–838. [
PubMed: 9039918]
Pfisterer RM. Retrospective verification of the diagnosis of anthrax by means of the intracutaneous skin test with the Russian allergen “Anthraxin” in a recent epidemic in Switzerland. Salisbury Medical Bulletin. 1990;68S:80.
Phillips AP, Campbell AM, Quinn R. Monoclonal antibodies against spore antigens of
Bacillus anthracis.
FEMS Microbiology and Immunology. 1988;47:169–178. [
PubMed: 2483677]
Phillips M, et al. Cutaneous anthrax associated with bioterrorism, United States, 2001; Proceedings of 52nd Epidemic Intelligence Service Conference. 2003.
Pienaar U de V. A second outbreak of anthrax amongst game animals in the Kruger National Park 5th June to 11th October, 1960. Koedoe. 1961;4:4–14.
Pienaar U de V. Epidemiology of anthrax in wild animals and the control of anthrax epizootics in the Kruger National Park, South Africa.
Federation Proceedings. 1967;26:1496–1502. [
PubMed: 6057768]
Piris-Giminez A, et al. High bactericidal efficiency of type IIA phospholipase A2 against
Bacillus anthracis and inhibition of its secretion by the lethal toxin.
Journal of Immunology. 2004;173:521–530. [
PubMed: 15210813]
Plotkin SA, et al. An epidemic of inhalation anthrax, the first in the twentieth century.
American Journal of Medicine. 1960;29:992–1001. [
PubMed: 13736379]
Pomerantsev AP, et al. Anthrax prophylaxis by antibiotic resistant STI-AR in combination with urgent antibiotic therapy. Salisbury Medical Bulletin. 1996;87S:131–132.
Popov SG, et al. Hemorrhagic and haemolytic anthrax pathogenic factors; Abstract of the ASM Biodefense Research Meeting; Baltimore, M.D., USA. 7-10 March 2004; 2004. abstract 220.
Price BM, et al. Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.
Infection and Immunity. 2001;69:4509–4515. [
PMC free article: PMC98526] [
PubMed: 11401993]
Provost A, Trouette M. [Latent anthrax in cattle]. Revue d’Elevage et de Médecine Vétérinaire des Pays Tropicaux. 1957;10:25–26. (In French)
Pugh AO, Davies JC. Human anthrax in Zimbabwe. Salisbury Medical Bulletin. 1990;68S:32–33.
Punskii EE, Zheglova DV. On the role of camels in the epidemiology of anthrax.
Journal of Microbiology, Epidemiology and Immunobiology. 1958;29:78–82. [
PubMed: 13570404]
Pyper JF, Willoughby L. An anthrax outbreak affecting man and buffalo in the Northwest territories.
Medical Services Journal, Canada. 1964;20:531–540. [
PubMed: 14181726]
Quesnel-Hellman A, et al. Anthrax edema toxin: does it play a role in immune evasion?; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; abstract P100.
Quinn CP, Turnbull PC. Anthrax. In: Collie L, et al., editors. Topley and Wilson’s microbiology and microbial infections. Ninth ed. Vol. 3. London: Arnold; 1998. pp. 799–818.
Quinn CP, et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen.
Emerging Infectious Diseases. 2002;8:1103–1110. [
PMC free article: PMC2730307] [
PubMed: 12396924]
Quinn CP, et al. Immune responses to
Bacillus anthracis protective antigen in individuals with bioterrorism-associated cutaneous and inhalation anthrax.
Journal of Infectious Diseases. 2004;190:1228–1236. [
PubMed: 15346332]
Ramisse V, et al. Identification and characterization of
Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA.
FEMS Microbiology Letters. 1996;145:9–16. [
PubMed: 8931320]
Ramisse V, et al. The Ba813 chromosomal DNA sequence effectively traces the whole
Bacillus anthracis community.
Journal of Applied Microbiology. 1999;87:224–228. [
PubMed: 10475954]
Rao NS, Mohiyudeen S. Tabanus flies as transmitters of anthrax – a field experience. Indian Veterinary Journal. 1958;35:348–353.
Read TD, et al. The genome sequence of
Bacillus anthracis Ames and comparison to closely related bacteria.
Nature. 2003;423:81–86. [
PubMed: 12721629]
Redmond C, et al. Bacteriology, serology and pathology of experimental anthrax in pigs. Salisbury Medical Bulletin. 1996;87S:79–82.
Redmond C, et al. Phage from different strains of Bacillus anthracis. Salisbury Medical Bulletin. 1996;87S:60–63.
Redmond C, et al. Experimentally assessed public health risks associated with pigs from farms experiencing anthrax.
Veterinary Record. 1997;141:244–247. [
PubMed: 9308148]
Redmond C, et al. Identification of proteins in the exosporium of
Bacillus anthracis.
Microbiology. 2004;150:355–363. [
PubMed: 14766913]
Reif TC, et al. Identification of capsule-forming
Bacillus anthracis spores with the PCR and a novel dual-probe hybridization format.
Applied and Environmental Microbiology. 1994;6:1622–1625. [
PMC free article: PMC201526] [
PubMed: 8017940]
Reissman DB, et al. One-year health assessment of adult survivors of
Bacillus anthracis infection.
Journal of the American Medical Association. 2004;291:1994–1998. [
PubMed: 15113818]
Rengel J. [Investigations on oral immunization with Bacillus anthracis strain 34F2 (Sterne)]. Göttinger Beiträge zur Land- und Forstwirtschaft in den Tropen und Subtropen. 1993;77 (In German)
Rengel J, Böhnel H. [Preliminary trials of oral immunization of wildlife against anthrax].
Berliner und Münchener Tieträrztliche Wochenschrift. 1994;107:145–149. (In German, summary in English) [
PubMed: 8067984]
Rengel J, Böhnel H. Preliminary experiments in oral immunization of wildlife against anthrax. Animal Research and Development. 1995;41:101–111.
Riedinger O. [Computation for the sterilization process in rendering plants].
Zentralblatt für Bakteriologie i Abt Originale B Hygiene. 1980;170:287–296. (In German, summary in English) [
PubMed: 6252725]
Riedinger O, Strauch D, Böhm R. [The destruction of pathogenic and non-pathogenic spore-formers by heat sterilization of slaughterhouse waste].
Zentralblatt für Veterinarmedizin Medizin Reihe B. 1975;22:860–865. (In German, summary in English) [
PubMed: 1217280]
Robertson ME. Progress in leather science 1920–1945. London: British Leather Manufacturer’s Research Association; 1948. Micro-organisms infective to workers in tanneries; pp. 117–121.
Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory route. Journal of Pathology and Bacteriology. 1957;73:485–494.
Saile E, Koehler TM.
Bacillus anthracis multiplication, persistence and genetic exchange in the rhizosphere of grass plants; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25-29 September 2005; 2005. abstract O7. [
PMC free article: PMC1472387] [
PubMed: 16672454]
Salmon DD, Ferrier GR. Post-vaccination occurrence of anthrax in cattle.
Veterinary Record. 1992;130:140–141. [
PubMed: 1557881]
Salmon DE. Special report on diseases of the horse. Washington, D.C.: Government Printing Office; 1896. Anthrax; pp. 526–530.
Sawada-Hirai R, et al. Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.
Journal of Immune Based Therapies and Vaccines. 2004;2:5–20. [
PMC free article: PMC420254] [
PubMed: 15140257]
Schlingman AS, et al. Immunizing activity of alum-precipitated protective antigen of
Bacillus anthracis in cattle, sheep and swine.
American Journal of Veterinary Research. 1956;17:256–261. [
PubMed: 13302649]
Schneerson R, et al. Poly(gamma-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of
Bacillus anthracis: a potential addition to the anthrax vaccine.
Proceedings of the National Academy of Sciences. 2003;100:8945–8950. [
PMC free article: PMC166418] [
PubMed: 12857944]
Schuch R, Nelson D, Fischetti VA. A bacteriolytic agent that detects and kills
Bacillus anthracis.
Nature. 2002;418:884–889. [
PubMed: 12192412]
Scobie HM, et al. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Proceedings of the National Academy of Sciences. 2003;100:5170–5174. [
PMC free article: PMC154317] [
PubMed: 12700348]
Sejvar JJ, Tenover FC, Stephens DS. Management of anthrax meningitis.
Lancet Infectious Diseases. 2005;5:287–295. [
PubMed: 15854884]
Seddon HR. Diseases of domestic animals in Australia. Vol. 1. Canberra: Department of Health; 1953. Anthrax; pp. 8–40. Part 5.
Sen SK, Minett FC. Experiments on the transmission of anthrax through flies. Indian Journal of Veterinary Science and Animal Husbandry. 1944;14:149–159.
Shaw A, Moss R, Boughey FD. Anthrax. State Veterinary Journal. 1963;18:64.
Shen Y, et al. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.
Proceedings of the National Academy of Sciences. 2004;101:3242–3247. [
PMC free article: PMC365774] [
PubMed: 14978283]
Shlyakhov EN.
Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii. 1953;28:7–48. (In Russian, cited without title by
Klein et al., 1962)
Shlyakhov EN. Second attacks. Salisbury Medical Bulletin. 1996;87S:139.
Shlyakhov EN, Rubinstein E. Human live anthrax vaccine in the former USSR.
Vaccine. 1994;12:727–730. [
PubMed: 8091851]
Shlyakhov E, Rubinstein E, Novikov I. Anthrax post-vaccinal cell-mediated immunity in humans: kinetics pattern.
Vaccine. 1997;15:631–636. [
PubMed: 9178463]
Sinderson HC. Recurrence of malignant pustule. British Medical Journal. 1933;1:612.
Singh Y, Chaudhary VK, Leppla SH. A deleted variant of
Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin.
Journal of Biological Chemistry. 1989;264:19103–19107. [
PubMed: 2509473]
Sirisanthana T, et al. Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with
Bacillus anthracis.
American Journal of Tropical Medicine and Hygiene. 1984;33:144–150. [
PubMed: 6696173]
Sirisanthana T, et al. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand.
American Journal of Tropical Medicine and Hygiene. 1988;39:575–581. [
PubMed: 3144920]
Sjöstedt A, et al. Detection of the vegetative form of Bacillus anthracis in soil by PCR. Salisbury Medical Bulletin. 1996;87S:50.
Sjöstedt A, et al. Detection of Bacillus anthracis spores in soil by PCR. FEMS Microbiological Ecology. 1997;23:159–168.
Slater C, Spitta EJ. An atlas of bacteriology. London: Scientific Press Ltd; 1898. Bacillus anthracis; pp. 24–31.
Smith H, Keppie J. Observations on experimental anthrax: demonstration of a specific lethal factor produced in vivo by
Bacillus anthracis.
Nature. 1954;173:869–871. [
PubMed: 13165673]
Smith NR, Gordon RE, Clark FE. Aerobic sporeforming bacteria. Washington, D.C.: United States Government Printing Office; 1952. United States Department of Agriculture, Agriculture Monograph 16.
Snoeyenbos GH. Brucellosis, anthrax, pseudo-tuberculosis, tetanus, vibrio infection, avian vibrionic hepatitis, and spirochetosis. In: Biester HE, Schwarte LH, editors. Diseases of poultry. Fifth ed. Ames: Iowa State University Press; 1965. pp. 427–450.
Somers F. Anthrax amongst wild animals in captivity. Veterinary Record. 1911;23:543–544.
Spears HN. The potency of anti-anthrax serum. British Veterinary Journal. 1955;111:535–537.
Sporn C, et al. A survey of use of the emergency department during a local public health crisis. Research Forum Abstracts. Annals of Emergency Medicine. 2002;40:S62.
St John-Brooks R. The non-pathogenic spore-bearing aerobic bacteria. In: Bulloc W, et al., editors. A system of bacteriology in relation to medicine. Vol. 5. London: HMSO; 1930. pp. 479–487.
Steele JH. Comments; Proceedings of the symposium on anthrax in man; University of Pennsylvania, Philadelphia, P.A.. 8 October 1954; 1954. p. 32.
Stepanov AS, Mikshis NI, Bolotnikova MF. Role of chromosomally-encoded factors in virulence of Bacillus anthracis for mice and guinea-pigs. Salisbury Medical Bulletin. 1996;87S:86–87.
Stepanov AS, et al. [Contribution of determinants, located in the
Bacillus anthracis chromosome, in realizing the pathogenic properties of the pathogen].
Molecular General Mikrobiology Virusology. 1999;1:20–23. (In Russian) [
PubMed: 10190106]
Stepanov AV, et al. Development of novel vaccines against anthrax in man.
Journal of Biotechnology. 1996;44:155–160. [
PubMed: 8717399]
Sterne M. Variation in Bacillus anthracis. Onderstepoort Journal of Veterinary Science and Animal Industry. 1937;8:271–349.
Sterne M. The effects of different carbon dioxide concentrations on the growth of virulent anthrax strains. Pathogenicity and immunity tests on guinea-pigs and sheep with anthrax variants derived from virulent strains. Onderstepoort Journal of Veterinary Science and Animal Industry. 1937;9:49–67.
Sterne M. The use of anthrax vaccines prepared from avirulent (uncapsulated) variants of Bacillus anthracis. Onderstepoort Journal of Veterinary Science and Animal Industry. 1939;13:307–312.
Sterne M. Avirulent anthrax vaccine.
Onderstepoort Journal of Veterinary Science and Animal Industry. 1946;21:41–43. [
PubMed: 20990776]
Sterne M. Anthrax. In: Stableforth AW, Galloway IA, editors. Infectious diseases of animals. Vol. 1. London: Butterworths; 1959. pp. 16–52. Diseases due to bacteria.
Sterne M. Anthrax. In: Dallin T, et al., editors. International encyclopaedia of veterinary medicine. Edinburgh: W. Green and Son Ltd; 1966. pp. 221–230.
Sterne M, Robinson EM, Nicol J. The use of saponin spore vaccine for inoculation against anthrax in South Africa. Onderstepoort Journal of Veterinary Science and Animal Industry. 1939;12:279–302.
Stiles GW. Isolation of the Bacillus anthracis from spinose ear ticks Ornithodorus megnini. American Journal of Veterinary Research. 1944;5:318–319.
Stockman S. The epizootiology of anthrax. Journal of Comparative Pathology and Therapeutics. 1911;24:97–108.
Strauch von D. [Elimination of animal carcasses – a persistent health challenge]. Wiener Tierärztliche Monatsschrift. 1991;78:217–233. (In German)
Sumerkan B, et al. Antimicrobial susceptibility of Bacillus anthracis against macrolides. Salisbury Medical Bulletin. 1996;87S:138.
Sussman AS, Halvorson HO. Spores Their dormancy and germination. New York: Harper and Row; 1966. pp. 132–140.pp. 193–212.
Sylvestre P, Couture-Tosi E, Mock M. A collagen-like surface glycoprotein is a structural component of the
Bacillus anthracis exosporium.
Molecular Microbiology. 2002;45:169–178. [
PubMed: 12100557]
Tanner WB, et al. Public health aspects of anthrax vaccination of dairy cattle. Journal of the American Veterinary Medical Association. 1978;173:1465–1466.
Tasyaran MS, Erol S. Penicillin therapy for anthrax: a reply to Torres-Tortosa et al. European Journal of Clinical Microbiology and Infectious Diseases. 2002;21:697.
Thomason B, Dixon TC, Hanna PC. Anthrolysin O: the cholesterol-dependent cytolysin of Bacillus anthracis; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract P75.
Thorne CB. Capsule formation and glutamyl polypeptide synthesis by Bacillus anthracis and Bacillus subtilis. In: Spooner ET, Stocker BA, editors. Bacterial anatomy. Cambridge: Cambridge University Press; 1956. pp. 68–80.
Titball RW, Manchee RJ. Factors affecting the germination of spores of
Bacillus anthracis.
Journal of Applied Bacteriology. 1987;62:269–273. [
PubMed: 3110118]
Titball RW, Turnbull PC, Hutson RA. The monitoring and detection of
Bacillus anthracis in the environment.
Society for Applied Bacteriology Symposium Series. 1991;20:9S–18S. [
PubMed: 1909461]
Tomaso H, et al. Growth characteristics of
Bacillus anthracis compared to other
Bacillus spp. on the selective nutrient media Anthrax Blood Agar® and Cereus Ident Agar®
Systematic and Applied Microbiology. 2006;29:24–28. [
PubMed: 16423652]
Tomcsik J, Ivanovics G. [The protective action of anthrax anticapsular immune substance to anthrax infection]. Zeitschrift für Immunitätsforschung. 1938;94:28–44. (In German)
Tonello F, et al. Anthrax toxins inhibit peripheral blood lymphocytes. Another immune system cell targeted by anthrax and a reevaluatoin of the role of anthrax edema factor; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O38.
Trnka Z, et al. [Experimental contributions to the lymphatic pathogenesis of anthrax infection].
Ceskoslovenska Mikrobiologie. 1958;5:82–91. (In Czech.) (Cited by
Lincoln et al., 1961) [
PubMed: 13624696]
Tsurkan AP, Shoismatulloev BS, Vermul MS. [Case of recurrent human anthrax occurring several weeks after the primary disease].
Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii. 1980;11:105–107. (In Russian, summary in English) [
PubMed: 7445847]
Tubbesing UH. An outbreak of anthrax amongst wild carnivore species held in captivity; Proceedings of a symposium on lions and leopards as game ranch animals; Onderstepoort, South Africa. October 1997; 1997. pp. 163–167.
Turell MJ, Knudson GB. Mechanical transmission of
Bacillus anthracis by stable flies (
Stomoxys calcitrans) and mosquitoes (
Aedes aegypti and
Aedes taeniorhynchus).
Infection and Immunity. 1987;55:1859–1861. [
PMC free article: PMC260614] [
PubMed: 3112013]
Turnbull P. Anthrax. In: Smith GR, Easmon CR, editors. Topley and Wilson’s principles of bacteriology, virology and immunity. Eighth ed. Vol. 3. Sevenoaks: Edward Arnold; 1990. pp. 365–379.
Turnbull PC. Terminal bacterial and toxin levels in the blood of guinea-pigs dying of anthrax. Salisbury Medical Bulletin. 1990;68S:53–55.
Turnbull PC. Anthrax vaccines: past, present and future.
Vaccine. 1991;9:533–539. [
PubMed: 1771966]
Turnbull PC. Guidance on environments known to be or suspected of being contaminated with anthrax spores. Land Contamination and Reclamation. 1996;4:37–45.
Turnbull PC. Current status of immunization against anthrax: old vaccines may be here to stay for a while.
Current Opinion in Infectious Diseases. 2000;13:113–120. [
PubMed: 11964777]
Turnbull PC, Kramer JM. Bacillus. In: Balow A, et al., editors. Manual of clinical microbiology. Fifth ed. Washington, D.C.: American Society for Microbiology; 1991. pp. 296–303.
Turnbull PC, Kramer JM. Bacillus. In: Murray PR, et al., editors. Manual of clinical microbiology. Sixth ed. Washington, D.C.: American Society for Microbiology; 1995. pp. 349–356.
Turnbull P, Bowen J, Mann J. Stubborn contamination with anthrax spores. Environmental Health. 1996;104:171–173.
Turnbull PC, Fowler K, Baillie L. Orally administered live spore vaccines fail to induce immunity against anthrax; Abstracts of the Fourth International Conference on Anthrax; St John’s College, Annapolis, M.D., USA. 10–13 June 2001; 2001. p. 25.
Turnbull PC, Frawley DA, Bull RL. Heat activation/shock temperatures for
Bacillus anthracis spores and the issue of spore plate counts versus true numbers of spores.
Journal of Microbiological Methods. 2006;68:353–357. [
PubMed: 17055602]
Turnbull PC, Kramer JM, Melling J. >Bacillus. In: Parker MT, Duerden BI, editors. Topley and Wilson’s principles of bacteriology, virology and immunity. Eighth ed. Vol. 2. Sevenoaks: Edward Arnold; 1990. pp. 187–210.
Turnbull PC, et al. Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea-pigs and their relevance to protective immunity.
Infection and Immunity. 1986;52:356–363. [
PMC free article: PMC261006] [
PubMed: 3084381]
Turnbull PC, et al. Antibodies to anthrax toxin in humans and guinea-pigs and their relevance to protective immunity.
Medical Microbiology and Immunology. 1988;177:293–303. [
PubMed: 3139974]
Turnbull PC, et al. Protection conferred by microbially-supplemented UK and purified PA vaccines. Salisbury Medical Bulletin. 1990;68S:89–91.
Turnbull PC, et al. Anthrax in wildlife in the Luangwa Valley, Zambia.
Veterinary Record. 1991;128:399–403. [
PubMed: 1907048]
Turnbull PC, et al.
Bacillus anthracis but not always anthrax.
Journal of Applied Bacteriology. 1992;72:21–28. [
PubMed: 1541596]
Turnbull PC, et al. Guidelines on surveillance and control of anthrax in humans and animals. Geneva: World Health Organization; 1998. (WHO/EMC/ZDI/98.6)
Turnbull PC, et al. Airborne movement of anthrax spores from carcass sites in the Etosha National Park, Namibia.
Journal of Applied Microbiology. 1998;84:667–676. [
PubMed: 9633664]
Turnbull PC, et al. Seroconversion in bison (Bison bison) in northwest Canada experiencing sporadic and epizootic anthrax; Abstracts of the Fourth International Conference on Anthrax; St John’s College, Annapolis, M.D., USA. 10-13 June 2001; 2001. p. 18.
Turnbull PC, et al. MICs of selected antibiotics for
Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis and
Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.
Journal of Clinical Microbiology. 2004;42:3626–3634. [
PMC free article: PMC497625] [
PubMed: 15297508]
Turnbull PC, et al. Vaccine-induced protection against anthrax in cheetah (Acinonyx jubatus) and black rhinoceros (
Diceros bicornis).
Vaccine. 2004;22:3340–3347. [
PubMed: 15308358]
Turnbull W, Abhayaratne P. 2002
WMD terrorism chronology: incidents involving subnational actors and chemical, biological, radiological, and nuclear materials (
http://cns.miis.edu/research/terror.htm).
Turner M. Anthrax in humans in Zimbabwe.
Central African Journal of Medicine. 1980;26:160–161. [
PubMed: 7407895]
Vallery-Radot R. The life of Pasteur. New York: Doubleday; 1923.
Van den Bosch C. Recalling an outbreak of gastrointestinal anthrax in northern Kenya, 1966. Salisbury Medical Bulletin. 1996;87S:139.
Van Ness GB. Ecology of anthrax.
Science. 1971;172:1303–1307. [
PubMed: 4996306]
Van Ness G, Stein CD. Soils of the United States favorable for anthrax.
Journal of the American Veterinary Medicine Association. 1956;128:7–10. [
PubMed: 13278269]
Viljoen PR, Curson HH, Fourie PJ. Anthrax in South Africa. Pretoria: Union Department of Agriculture; 1928. pp. 431–528. 13th and 14th reports of the Director of Veterinary Education and Research.
Vitale G, et al. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
Biochimica Biophysica Research Communications. 1998;248:706–711. [
PubMed: 9703991]
Wade BH, et al. Anthrax toxin components stimulate chemotaxis of human polymorphonuclear neutrophils.
Proceedings of the Society for Experimental Biology and Medicine. 1985;179:159–162. [
PubMed: 2986152]
Walker RI, Owen RL. Intestinal barriers to bacteria and their toxins.
Annual Review of Medicine. 1990;41:393–400. [
PubMed: 2184739]
Wang TT, et al. Induction of opsonic antibodies to the gamma-D-glutamic acid capsule of
Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate.
FEMS Immunology and Medical Microbiology. 2004;40:231–237. [
PubMed: 15039099]
Warfel JM, Steele AD, D’Agnillo F. Endothelial responses to anthrax lethal toxin; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25–29 September 2005; 2005. abstract O14.
Webster A. Inhibiting effect of antibiotics on anthrax vaccination.
Australian Veterinary Journal. 1973;49:545. [
PubMed: 4784197]
Weidlich N. Prolonged colonization of the udder of a cow by anthrax bacilli. Veterinary Record. 1935;15:404.
Weis CP, et al. Secondary aerosolization of viable
Bacillus anthracis spores in a contaminated US Senate office.
Journal of the American Medical Association. 2002;288:2853–2858. [
PubMed: 12472327]
Welkos SL. Plasmid-associated virulence factors of non-toxigenic (pX01-)
Bacillus anthracis.
Microbial Pathogenesis. 1991;10:183–198. [
PubMed: 1654495]
Welkos SL, et al. Resistance to the Sterne strain of
B. anthracis: phagocytic cell responses of resistant and susceptible mice.
Microbial Pathogenesis. 1989;7:15–35. [
PubMed: 2509851]
Welkos SL, et al. Pathogenesis and host resistance to Bacillus anthracis: a mouse model. Salisbury Medical Bulletin. 1990;68S:49–52.
Welkos S, et al. In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.
Journal of Medical Microbiology. 2002;51:821–831. [
PubMed: 12435060]
Wheelis M. Biological sabotage in World War I. In: Geissle E, van Courtland Moon JE, editors. Biological and toxin weapons: research, development and use from the Middle Ages to 1945. Oxford: Oxford University Press; 1999. pp. 35–62. SIPRI Chemical and Biological Warfare Studies, 18.
Whitby LE. Medical bacteriology, descriptive and applied. London: J & A Churchill; 1928. Anthrax; pp. 134–137.
Whitford HW. Anthrax. In: Steele JH, editor. CRC handbook series in zoonoses, Section A Bacterial, rickettsial and mycotic diseases. Vol. 1. Boca Raton: CRC Press; 1979. pp. 31–66.
Whitworth SH.
The influence of hydrogen ion concentration on the biology of the anthrax organism. Zurich: University of Zurich; 1924. [Thesis] (Cited by
Van Ness, 1971)
WHO. Requirements for anthrax spore vaccine (live – for veterinary use) (requirements for biological substances 13). Geneva: World Health Organization; 1967. (WHO Technical Report Series No. 361)
WHO. Formaldehyde health and safety guide. Geneva: World Health Organization; 1991. (Health and Safety Guide 57)
WHO. Disease outbreak in Kenya: WHO does not recommend travel restrictions. 1997. Press release WHO/101, 30 December 1997.
WHO. WHO recommended surveillance standards. Geneva: World Health Organization; 1997. (WHO/EMC/DIS/97.1)
WHO. Manual for laboratory diagnosis of anthrax. New Delhi: WHO Regional Office for South-East Asia; 2003. (SEAHLM-371)
WHO. The public health response to biological and chemical weapons. Geneva: World Health Organization; 2004.
WHO. Guidance on regulations for the transport of infectious substances 2007–2008. Geneva: World Health Organization; 2007. (WHO/CDS/EPR/2007.2)
Wild MA, et al. Human antibodies from immunized donors are protective against anthrax toxin in vivo.
Nature Biotechnology. 2003;21:1305–1306. [
PubMed: 14555959]
Williams DD, Turnbough CL. Surface layer protein EA1 is not a component of
Bacillus anthracis spores but is a persistent contaminant in spore preparations.
Journal of Bacteriology. 2004;186:566–569. [
PMC free article: PMC305771] [
PubMed: 14702325]
Williams DR, Rees GB, Rogers ME. Observations on an outbreak of anthrax in pigs in north Wales.
Veterinary Record. 1992;131:363–366. [
PubMed: 1441152]
Williams NF. Anthrax Journal of the American Veterinary Medical Association. 1932;81:9–25.
Wilson DC, Stevens C. Problems arising from the redevelopment of gas works and similar sites. London: HMSO; 1981. AERE Harwell report R-10366.
Wise GA, Kennedy DJ. Anthrax in south-western NSW. New South Wales Veterinary Proceedings. 1980;16:55–59.
Witzmann C, Böhm R. Specificity of monoclonal antibodies against vegetative cells of Bacillus anthracis. Salisbury Medical Bulletin. 1990;68S:25–26.
Young GA, Zelle MR, Lincoln RE. Respiratory pathogenicity of
Bacillus anthracis spores. 1. Methods of study and observations on pathogenesis.
Journal of Infectious Diseases. 1946;79:233–271. [
PubMed: 20278392]
Young SE, Healing TD. Infection in the deceased: a survey of management.
PHLS Communicable Disease Report. 1995;5:R69–R73. [
PubMed: 7749456]
Yu L, et al. PHPS efforts associated with an anthrax epizootic in Texas, 2001; Proceedings of the annual meeting of the Public Health Prevention Service, 2002. 2002.
Zaucha GM, et al. The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation.
Archives of Pathological Laboratory Medicine. 1998;122:982–992. [
PubMed: 9822127]
Zenewicz L, Atherly L, Shen H. Early innate response following intranasal immunization with spores of Bacillus anthracis Sterne vaccine; Abstracts of the Bacillus ACGT Conference; Santa Fe, N.M., USA. 25-29 September 2005; 2005. abstract O48.
Zwartouw HT, Smith H. Non-identity of the phospholipase of
Bacillus anthracis with the anthrax toxin.
Journal of General Microbiology. 1956;15:261–265. [
PubMed: 13376868]
